Skip to main content
. 2020 Nov 22;18(11):951–960. doi: 10.18502/ijrm.v13i11.7962

Table 3.

Pregnancy outcomes mock and control groups (ITT and per protocol analyses)


Analysis by ITT (n = 200) MOCK (n = 106) Control (n = 94) Relative risk (95% CI) P-value
Clinical pregnancy rate 43/106 (40.56) 38/94 (40.42) 1.0035 (0.7167-1.4051) 0.98
Live birth rate 31/106 (29.24) 25/94 (26.59) 1.0996 (0.7027-1.7207) 0.67
Miscarriage rate 10/47 (21.27) 13/38 (34.21) 0.6219 (0.3073-1.2585) 0.18
Multiple pregnancy rate 3/43 (6.97) 3/38 (7.89) 0.8837 (0.1895-4.1209) 0.87
Analysis per protocol /ET (n = 184) Mock (n = 97) Control (n = 87 ) Relative risk (95% CI) P-value
Clinical pregnancy rate 43/97 (44.32) 38/87 (43.67) 1.0149 (0.7321-1.4069) 0.92
Live birth rate 31/97 (31.95) 25/87 (28.73) 1.1122 (0.7161-1.7273) 0.47
Miscarriage rate 10/47 (21.27) 13/38 (34.21) 0.6219 (0.3073-1.2585) 0.18
Multiple pregnancy rate 3/43 (6.97) 3/38 (7.89) 0.8837 (0.1895-4.1209) 0.87
Data presented as n (%), ITT: Intension to treat, Chi-squared test, P-value < 0.05 was considered as significant. Clinical pregnancy: Detection of heart activity on the ultrasound scan; Live birth rate: The percentage of all cycles that lead to live birth (more than 20 wk)